Go beyond the consensus and become a better stock picker with Earnings Whisper numbers, investor sentiment, and proprietary research and tools to help you capture the Post-Earnings Announcement Drift (PEAD) and outperform the overall stock market. Plus, get the most accurate earnings dates, earnings news, and insights into how stocks react before
and after earnings.
CAJPYCanonis confirmed to report Tuesday, October 27, before the open.
Canon Tests Its Highs Into September-Quarter Results as Sentiment Turns Cautious
Canon heads into its September-quarter report with an unusual split between price and mood. The shares have climbed 7.7% since the company last reported, beating the S&P 500 by more than five percentage points, and now sit within a whisker of their post-earnings high. Yet sentiment among retail investors has soured, sliding to 28.3% bearish from 14.0% bearish ahead of the prior report. A stock that keeps rising while the crowd grows more skeptical raises the question this release must settle: is the rally resting on durable earnings power, or has it run ahead of the fundamentals?
The numbers set an undemanding hurdle on one measure and a tougher one on another. In the year-ago September quarter, Canon earned $0.48 per share on revenue of $7.49 billion. Last quarter it earned $0.89 per share on $7.41 billion in sales, nearly double the year-ago figure on slightly lower revenue. That gap is the heart of the setup. If Canon can deliver anything close to last quarter's profitability on a similar revenue base, the year-over-year comparison will look dramatic. But the more meaningful test is whether the margin structure behind that $0.89 holds, because the top line itself has not been growing. Revenue roughly flat against last year means earnings gains have to come from mix, pricing, cost discipline or currency rather than volume. No clear published consensus figure is available to anchor expectations, and management has not offered fresh quantitative guidance since the last report, so the market will judge the quarter largely against Canon's own recent run rate.
Southwest Airlines (LUV) reported earnings of $0.66 per share on revenue of $8.42 billion for the third quarter ended September 2026. The consensus earnings estimate was $0.61 per share on revenue of $8.26 billion. The Earnings Whisper number was $0.50 per share. The company beat expectations by 32.00% while revenue grew 21.20% on a year-over-year basis.
The company said it expects fourth quarter non-GAAP earnings of $0.55 to $0.80 per share. The current consensus earnings estimate is $0.99 per share for the quarter ending December 31, 2026.
Southwest Airlines Co is an operator of passenger airline that provides scheduled air transportation in the United States and international markets.
CACI International (CACI) reported earnings of $7.66 per share on revenue of $2.47 billion for the fiscal first quarter ended September 2026. The consensus earnings estimate was $6.45 per share on revenue of $2.50 billion. The Earnings Whisper number was $6.74 per share. The company beat expectations by 13.65% while revenue grew 8.17% on a year-over-year basis.
The company said it now expects fiscal 2027 non-GAAP earnings of $33.18 to $34.08 per share on revenue of $10.7 billion to $10.9 billion. The company's previous guidance was non-GAAP earnings of $32.96 to $33.86 per share on revenue of $10.7 billion to $10.9 billion. The current consensus earnings estimate is $32.24 per share on revenue of $10.8 billion for the year ending June 30, 2027.
CACI International Inc is a provider of information solutions and services to the U.S. government. Its segments include domestic operations and international operations.
Medpace (MEDP) reported earnings of $4.84 per share on revenue of $716.00 million for the third quarter ended September 2026. The consensus earnings estimate was $4.45 per share on revenue of $708.75 million. The Earnings Whisper number was $4.64 per share. The company beat expectations by 4.31% while revenue grew 8.50% on a year-over-year basis.
The company said it now expects 2026 earnings of $17.97 to $18.32 per share on revenue of $2.835 billion to $2.855 billion. The company's previous guidance was earnings of $17.25 to $17.95 per share on revenue of $2.805 billion to $2.885 billion. The current consensus earnings estimate is $17.54 per share on revenue of $2.840 billion for the year ending December 31, 2026.
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries.
For more than 25 years, investors and financial professionals have used
Earnings Whispers to look beyond consensus estimates and better understand
the expectations driving stock prices around earnings.
